Complement Factor D Inhibitor

This page covers all Complement Factor D Inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Complement Factor D.

Targets

Complement Factor D

Marketed (1)

• DANICOPAN · Other
  Danicopan is a selective inhibitor of complement Factor D, preventing the cleavage of Factor B and the formation of the C3 convertase in the alternative complement pathway.

Phase 3 pipeline (1)

• CYB704 · Sandoz · Immunology
  CYB704 is a selective inhibitor of complement factor D that reduces complement cascade activation and downstream inflammatory responses.